AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR
Report
- Report Number
- 1018233-2013-02689
- Event Type
- Injury
- Date Received
- July 3, 2013
- Report Date
- August 29, 2016
- Manufacturer
- C.R. BARD, INC.
- Product Code
- OTP
- PMA / PMN Number
- K082571
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- ATTORNEY
Narratives
THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: "POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE." (B)(4).
(B)(4)
(B)(4). THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD'L INFO HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDR 1018233-2013-02690.
PER ADDITIONAL INFORMATION RECEIVED, THE PATIENT HAS EXPERIENCED MESH EROSION, PAIN DURING INTERCOURSE, URINE LEAKAGE, BLOOD LOSS, URINARY TRACT INFECTION, LOW BACK PAIN, ELEVATED BLOOD PRESSURE, BODY ACHES, FREQUENCY, URGENCY, BILATERAL COSTOVERTEBRAL ANGLE TENDERNESS, SUPRAPUBIC PRESSURE WITH PALPATION, BACTERIA, EPITHELIALS, WHITE BLOOD CELLS IN URINE, PELVIC PAIN, LUMBAR RADICULOPATHY, FATIGUE, LOSES CONTROL OF URINE AND NONSURGICAL INTERVENTIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 305092 | AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR | AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR | OTP | C.R. BARD, INC. | NA | CVRFX094 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Required Intervention | LOT CVRFX091, PRODUCT # 486201 |